BioCentury
ARTICLE | Company News

Nucleis SA, RNAx sales and marketing update

September 26, 2005 7:00 AM UTC

Nucleis and RNAx will co-market shRNA target validation technology. The deal combines Nucleis' Speedy Mouse transgenic animal generation technology with RNAx's shRNA constructs. ...